People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Pharmaceuticals, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| QUATRX PHARMACEUTICALS Co | — | Pharmaceuticals | Series A | $14.0M | $434.4M | 2009 |
| Lakril Technologies Corp | — | Software / Tech | Seed | $2.9M | $12.1M | 2024 |
Christopher Nicholas at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christopher Nicholas on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Heron | 1 | 11 |
| Chris Ehrlich | 1 | 6 |
| Anders Hove | 1 | 4 |
| Nick Simon | 1 | 3 |
| Neal Gutterson | 1 | 3 |
| Robert L. Zerbe | 1 | 2 |
| Rick Fox | 1 | 2 |
| Mel Luetkens | 1 | 2 |
| Stuart Dombey | 1 | 1 |
| Chris Moller | 1 | 1 |
| Gary Onn | 1 | 1 |
| Jeffery M Brinza | 1 | 1 |
| Anders Wiklund | 1 | 1 |
| August Watanabe | 1 | 1 |
| Andy Shafer | 1 | 1 |
| Lisa Dufresne | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.